Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Global coalition launched to protect against epidemics
vaccine
CEPI aims to lessen the amount of time it takes to develop new vaccines.
Project aims to reduce time it takes to develop new vaccines

A new global partnership to prevent epidemics with vaccines has launched at the World Economic Forum in Davos, Switzerland.

The Coalition for Epidemic Preparedness (CEPI) seeks to outsmart emerging infectious diseases by developing safe and effective vaccines before they emerge.

The project is funded by the governments of Germany, Norway, Japan, the Bill and Melinda Gates Foundation and the Wellcome Trust.

“Ebola and Zika showed that the world is tragically unprepared to detect local outbreaks and respond quickly enough to prevent them from becoming global pandemics. Without investments in research and development, we will remain unequipped when we face the next threat,” said Bill Gates, chair of the Bill and Melinda Gates Foundation.

“The ability to rapidly develop and deliver vaccines when new ‘unknown’ diseases emerge offers our best hope to outpace outbreaks, save lives and avert disastrous economic consequences. CEPI is a great example of how supporting innovation and R&D can help the world to address some of its most pressing health challenges.”

CEPI also aims to lessen the amount of time it takes to develop new vaccines by capitalising on developments in adaptable vaccine technology and investing in facilities that could respond quickly to previously unknown pathogens.

So far, the partnership has already raised half of the $1bn it needs for its first five years. It is now calling on researchers and companies around the world to support the development of the development of vaccines against its first target diseases.

To start, CEPI will target the MERS-CoV, Lassa and Nipah viruses. It aims to develop two promising vaccine candidates against each of these diseases before they cause serious epidemics.

CEPI will also look for potential support for vaccines against the various strains of Zika, Ebola ad Marburg viruses.

“We know from Ebola, Zika and SARS that epidemics are among the significant threats we face to life, health and prosperity,” said Dr Jeremy Farrar, director of the Wellcome Trust.

“Vaccines can protect us, but we’ve done too little to develop them as an insurance policy. CEPI is our chance to learn the lessons of recent tragedies, and outsmart epidemics with new vaccine defences. If others join us in supporting CEPI, we can realise our goal of creating a safer world.” 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
NSA webinar explores sheep tailing and castration

The National Sheep Association (NSA) is to host a free webinar on the castration and tail docking of lambs.

The webinar, 'Understanding the tailing and castration consultation: A guide for sheep farmers', will be hosted online on Monday, 2 March 2026 at 7.30pm.

It comes during a government consultation into the methods used for these procedures. Farmers are encouraged to engage before the consultation period closes on Monday, 9 March 2026.

The webinar offers clear and actionable guidance to support farmers to contribute meaningfully to the consultation and prepare for potential changes.

On the panel will be former SVS president Kate Hovers, farmer and vet Ann Van Eetvelt and SRUC professor in Animal Health and Veterinary Sciences Cathy Dwyer. Each panel member will utilise their own specialism and expertise to evaluate risks and outcomes to sheep farming.

Find out more about the webinar on the NSA website.